Regeneron hit with FDA rejection for blood cancer therapy
The agency said it required the confirmatory portion of odronextamab’s Phase III trial.
27 March 2024
27 March 2024
The agency said it required the confirmatory portion of odronextamab’s Phase III trial.
Bormioli Pharma, a leading international manufacturer of pharmaceutical packaging and medical devices, today announced a significant increase of 47% in its North American sales for 2023.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.